BEIJING, Aug. 30 (Xinhua) -- The following is a summary of published science and technology news of China.
A recombinant COVID-19 fusion protein vaccine (V-01) developed and manufactured in China has been approved for phase-III clinical trials in the Philippines.
The vaccine V-01 was developed by the Institute of Biophysics under the Chinese Academy of Sciences and Livzon Pharmaceutical Group Inc. (LivzonBio) in south China's Guangdong Province.
China's Mars rover Zhurong has spent 100 days exploring the red planet's surface since it first set its wheels on Martian soil on May 22, according to the China National Space Administration (CNSA) on Monday.
The rover is part of China's Tianwen-1 mission that also consists of an orbiter and a lander. The mission was launched on July 23, 2020.
China's central bank issued a set of commemorative coins Monday to celebrate the success of the country's first Mars mission.
The commemorative set contains two gold coins and one silver coin. Enditem